Published in J Pharm Sci on June 01, 2009
Fluorescent sensors for measuring metal ions in living systems. Chem Rev (2014) 1.71
Visualizing metal ions in cells: an overview of analytical techniques, approaches, and probes. Biochim Biophys Acta (2012) 1.10
Probing oxidative stress: Small molecule fluorescent sensors of metal ions, reactive oxygen species, and thiols. Coord Chem Rev (2012) 0.90
Drug-induced reactivation of apoptosis abrogates HIV-1 infection. PLoS One (2013) 0.87
Iron Deficiency Impairs Intra-Hepatic Lymphocyte Mediated Immune Response. PLoS One (2015) 0.75
Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med (2003) 3.24
Identification of an intestinal heme transporter. Cell (2005) 3.05
Chemistry and biology of siderophores. Nat Prod Rep (2010) 2.81
Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. Immunity (2006) 2.61
Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. Proc Natl Acad Sci U S A (2004) 2.49
The Pseudomonas aeruginosa 4-quinolone signal molecules HHQ and PQS play multifunctional roles in quorum sensing and iron entrapment. Chem Biol (2007) 2.05
Innate immunity in tuberculosis: myths and truth. Microbes Infect (2008) 2.00
Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis. J Exp Med (2002) 1.93
Saposin C is required for lipid presentation by human CD1b. Nat Immunol (2004) 1.88
Containment of aerogenic Mycobacterium tuberculosis infection in mice does not require MyD88 adaptor function for TLR2, -4 and -9. Eur J Immunol (2008) 1.59
Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis (2003) 1.57
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica (2009) 1.51
Interferon gamma activated macrophages kill mycobacteria by nitric oxide induced apoptosis. PLoS One (2011) 1.46
Release of redox-active iron by muscle crush trauma: no liberation into the circulation. Shock (2010) 1.44
Sensitive detection of gene expression in mycobacteria under replicating and non-replicating conditions using optimized far-red reporters. PLoS One (2010) 1.44
The IFN-inducible Golgi- and endoplasmic reticulum- associated 47-kDa GTPase IIGP is transiently expressed during listeriosis. J Immunol (2002) 1.34
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol (2005) 1.32
Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic (2005) 1.32
Iron chelators can protect against oxidative stress through ferryl heme reduction. Free Radic Biol Med (2007) 1.31
Complementary analysis of the Mycobacterium tuberculosis proteome by two-dimensional electrophoresis and isotope-coded affinity tag technology. Mol Cell Proteomics (2003) 1.29
Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide. Cell Microbiol (2008) 1.26
Apoptosis paves the detour path for CD8 T cell activation against intracellular bacteria. Cell Microbiol (2004) 1.26
Metals ions and neurodegeneration. Biometals (2007) 1.24
A role for IL-18 in protective immunity against Mycobacterium tuberculosis. Eur J Immunol (2010) 1.22
Design of clinically useful iron(III)-selective chelators. Med Res Rev (2002) 1.21
Tyrosine as a redox-active center in electron transfer to ferryl heme in globins. Free Radic Biol Med (2007) 1.19
Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera. J Biol Inorg Chem (2007) 1.18
Escape of Mycobacterium tuberculosis from oxidative killing by neutrophils. Cell Microbiol (2012) 1.17
Macrophage defense mechanisms against intracellular bacteria. Immunol Rev (2015) 1.17
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform. Anal Biochem (2005) 1.16
The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front Immunol (2013) 1.15
Critical role of NK cells rather than V alpha 14(+)NKT cells in lipopolysaccharide-induced lethal shock in mice. J Immunol (2002) 1.14
Design, synthesis, physicochemical properties, and evaluation of novel iron chelators with fluorescent sensors. J Med Chem (2004) 1.14
Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassaemia major: application of SQUID biomagnetic liver susceptometry. Br J Haematol (2003) 1.13
Feruloyl-CoA 6'-Hydroxylase1-dependent coumarins mediate iron acquisition from alkaline substrates in Arabidopsis. Plant Physiol (2013) 1.10
Iron(III) citrate speciation in aqueous solution. Dalton Trans (2009) 1.09
Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol (2010) 1.08
100th anniversary of Robert Koch's Nobel Prize for the discovery of the tubercle bacillus. Trends Microbiol (2005) 1.07
Use of electronic medical records (EMR) for oncology outcomes research: assessing the comparability of EMR information to patient registry and health claims data. Clin Epidemiol (2011) 1.07
Lipid-binding proteins in membrane digestion, antigen presentation, and antimicrobial defense. J Biol Chem (2005) 1.06
Design of iron chelators with therapeutic application. Dalton Trans (2012) 1.06
Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst. J Immunol (2002) 1.04
Haem and folate transport by proton-coupled folate transporter/haem carrier protein 1 (SLC46A1). Br J Nutr (2008) 1.04
Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics (2006) 1.04
Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights. J Hepatol (2002) 1.04
Serum iron curves can be used to estimate dietary iron bioavailability in humans. J Nutr (2006) 1.03
Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur J Immunol (2008) 1.03
A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging. J Antimicrob Chemother (2012) 1.02
Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciation. Biochim Biophys Acta (2009) 1.01
CD1 antigen presentation by human dendritic cells as a target for herpes simplex virus immune evasion. J Immunol (2006) 1.01
Proteophosophoglycans regurgitated by Leishmania-infected sand flies target the L-arginine metabolism of host macrophages to promote parasite survival. PLoS Pathog (2009) 1.01
Novel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorhiza. Planta Med (2004) 1.00
New challenges in studying nutrition-disease interactions in the developing world. J Clin Invest (2008) 0.98
Rapid in vivo assessment of drug efficacy against Mycobacterium tuberculosis using an improved firefly luciferase. J Antimicrob Chemother (2013) 0.98
Quantification of hepcidin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom (2009) 0.98
Antigen presentation and recognition in bacterial infections. Curr Opin Immunol (2005) 0.97
Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B. Dalton Trans (2015) 0.97
Genetic epidemiology of induced CYP3A4 activity. Pharmacogenet Genomics (2011) 0.95
Iron speciation in the cytosol: an overview. Dalton Trans (2012) 0.95
Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom (2010) 0.94
Quantitation of hepcidin in human urine by liquid chromatography-mass spectrometry. Anal Biochem (2008) 0.93
Identification of a new hexadentate iron chelator capable of restricting the intramacrophagic growth of Mycobacterium avium. Microbes Infect (2010) 0.93
Iron binding dendrimers: a novel approach for the treatment of haemochromatosis. J Med Chem (2006) 0.93
Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands. Chem Commun (Camb) (2011) 0.93
Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease. Br J Nutr (2011) 0.93
Common presence of non-transferrin-bound iron among patients with type 2 diabetes. Diabetes Care (2006) 0.92
Natural killer T-cell characterization through gene expression profiling: an account of versatility bridging T helper type 1 (Th1), Th2 and Th17 immune responses. Immunology (2007) 0.91
An improved strategy for selective and efficient enrichment of integral plasma membrane proteins of mycobacteria. Proteomics (2007) 0.91
Iron mobilization from transferrin by therapeutic iron chelating agents. Biochim Biophys Acta (2011) 0.90
Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone. Transl Res (2010) 0.90
Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells. J Neurochem (2008) 0.89
Charge states of deferasirox-ferric iron complexes. Am J Kidney Dis (2010) 0.88
Targeting the lysosome: fluorescent iron(III) chelators to selectively monitor endosomal/lysosomal labile iron pools. J Med Chem (2008) 0.88
A dangerous liaison between two major killers: Mycobacterium tuberculosis and HIV target dendritic cells through DC-SIGN. J Exp Med (2003) 0.87
Systemic administration of tolerogenic dendritic cells ameliorates murine inflammatory arthritis. Open Rheumatol J (2008) 0.87
Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes. Biochem J (2006) 0.87
Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation. J Virol (2006) 0.87
IL-17A promotes macrophage effector mechanisms against Trypanosoma cruzi by trapping parasites in the endolysosomal compartment. Immunobiology (2012) 0.86
Basic 3-hydroxypyridin-4-ones: potential antimalarial agents. Eur J Med Chem (2007) 0.86
Relevant activities of extracts and constituents of animals used in traditional Chinese medicine for central nervous system effects associated with Alzheimer's disease. J Pharm Pharmacol (2006) 0.86
Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators. J Med Chem (2002) 0.86
Protein identification and tracking in two-dimensional electrophoretic gels by minimal protein identifiers. Proteomics (2004) 0.85
Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLoS One (2012) 0.85
IL-4 and T cells are required for the generation of IgG1 isotype antibodies against cardiolipin. J Immunol (2002) 0.84
Fenton chemistry and iron chelation under physiologically relevant conditions: Electrochemistry and kinetics. Chem Res Toxicol (2006) 0.84
Induction of hypoxia inducible factor (HIF-1α) in rat kidneys by iron chelation with the hydroxypyridinone, CP94. Biochim Biophys Acta (2011) 0.83
Incorporation of 2,3-diaminopropionic acid into linear cationic amphipathic peptides produces pH-sensitive vectors. Chembiochem (2010) 0.83
Amides from Piper nigrum L. with dissimilar effects on melanocyte proliferation in-vitro. J Pharm Pharmacol (2007) 0.82
Synthesis of double-clickable functionalised graphene oxide for biological applications. Chem Commun (Camb) (2015) 0.82
Synthesis and antiviral evaluation of 3-hydroxy-2-methylpyridin-4-one dideoxynucleoside derivatives. Bioorg Med Chem Lett (2003) 0.82
Fluorescent 3-hydroxy-4-pyridinone hexadentate iron chelators: intracellular distribution and the relevance to antimycobacterial properties. J Biol Inorg Chem (2010) 0.81